RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of melanoma patients

Head :
Pr Dréno Brigitte, CRCINA - Unité Inserm U1232 - Responsable Equipe 2 "Clinical and translational research in skin cancer"
Pr Lebbe Céleste

Last update : 11/05/2020 | Version : 5 | ID : 5135

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Network for Research and Clinical Investigation on Melanoma - French national cohort of melanoma patients
Sign or acronym RIC-Mel Network
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL: EGY/EM/AR124131
General Aspects
Medical area Cancer research
Dermatology, venereology
Pathology (details) Melanoma
Keywords Melanoma, network, cohort, epidemiology, preclinical to phase III studies, national, european and international instances, fondamental and translational research.
Scientific investigator(s) (Contact)
Name of the director Pr Dréno
Surname Brigitte
Address CHU de Nantes
Service de Dermatologie
Site Hôtel Dieu
1, place Alexis Ricordeau
44093 Nantes cedex 01
Phone -
Email brigitte.dreno@atlanmed.fr
Unit CRCINA - Unité Inserm U1232 - Responsable Equipe 2 "Clinical and translational research in skin cancer"
Organization Centre de Recherche en Cancérologie et Immunologie Nantes Angers
Name of the director Pr Lebbe
Surname Céleste
Address Assistance Publique des Hôpitaux de Paris
Hôpital Saint Louis
Service de Dermatologie
1, avenue Claude Vellefaux
75010 Paris
Phone -
Email celeste.lebbe@sls.aphp.fr
Organization Hôpital Saint-Louis (AP-HP)
Collaborations
Participation in projects, networks and consortia Yes
Details Our partners : the Cancerology Group (GCC) of the French Society of Dermatology (SFD), the clinico-biologico-radiological database MELBASE, the Ile de France Melanoma network, the Far West Biotherapies and Researches in Dermatology network (BIORDERM), the West Melanoma Network and the patients association AMESA.
Funding
Funding status Mixed
Details -
Governance of the database
Sponsor(s) or organisation(s) responsible CHU de Nantes - RIC-Mel coordinating center
Organisation status Public
Sponsor(s) or organisation(s) responsible Cancerology Group (GCC) of the French Society of Dermatology (SFD)
Organisation status Public
Presence of scientific or steering committees Yes
Additional contact
Name of the contact Varey (Chef de projet)
Surname Emilie
Address CHU de Nantes - Hôtel Dieu
1, place Alexis Ricordeau
44093 NANTES Cedex 01
Phone 02 40 08 78 85
Email emilie.varey@chu-nantes.fr
Organization CHU de Nantes
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. After 7 years in existence, 23,971 patients have been included in database by our 49 participating centers.
Database objective
Main objective - To federate the clinical cancerology and dermatology sites as well as the existing networks in melanoma around a common database,
- To be a preferred interlocutor for the industry,
- To ensure close interaction between all the hospital disciplines involved in melanoma evolution,
- To ensure the functioning of a clinica ldatabase,
- To ensure interactions between clinical and translational research as well as to support basic research.
Inclusion criteria Patients with melanoma, regardless of the location of the primary tumour (cutaneous, mucosal, ocular or unknown) and the stage, and who have accepted to participate.
Population type
Age Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology C00-C97 - Malignant neoplasms
Gender Male
Woman
Geography area National
Detail of the geography area France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) March 2012
Size of the database
Size of the database (number of individuals) Greater than 20 000 individuals
Details of the number of individuals 23,971 patients (1 April, 2019)
Data
Database activity Current data collection
Type of data collected Clinical data
Clinical data (detail) Direct physical measures
Medical registration
Details of collected clinical data Data relating to the primitiv tumour, disease evolution (stage, treatments...) until death.
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Data are collected during patient follow-up, after expressing its consent
Participant monitoring Yes
Details on monitoring of participants Patients come as part of their usual medical care. The updating of data only occurs in case of disease progression and until the death.
Links to administrative sources No
Promotion and access
Promotion
Link to the document Plaquette_informative_du_réseau_RIC-Mel,RIC-Mel-DI-002,v.07.pdf
Link to the document Book_académique_RIC-Mel_CID_2016.pdf
Description Academic book oh the RIC-Mel network created for the Cohort Innovation Day 2016, organised byAVIESAN and ARIIS with the support of INSERM Transfert
Link to the document Poster_IID_DRAFT_5.pdf
Description Poster presented at the International Investigative Dermatology congress in 2018
Other information First publication : Dalle S. et al., Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database. Eur J Dermatol . 2020, 30(4):389-396
Access
Presence of document that lists variables and coding procedures Yes
Terms of data access (charter for data provision, format of data, availability delay) Please contact :

Mr Amir KHAMMARI
Deputy coordinator of the RIC-Mel network
Tel. : +33 2.40.08.32.80
Mail : amir.khammari@chu-nantes.fr

Mrs Emilie VAREY
Project manager of the RIC-Mel network
Tel. : +33 2.40.08.78.85
Mail : emilie.varey@chu-nantes.fr
Access to aggregated data Access on specific project only
Access to individual data No access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05